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A Case Report Discussing an Uncommon Peripheral Exudative Hemorrhagic 
Chorioretinopathy 
Abstract 
Purpose: The purpose of this case report is to discuss an uncommon, unique hemorrhagic 
chorioretinopathy. Method: A 79-year-old-white female presented to clinic with complaints of difficulty 
reading at close distances and seeing faces at far distances in both eyes. An 85-year old white female 
presented with no visual complaints but stated redness in the nasal corner of her right eye. This is a case 
report of two patients that presented with geographic atrophy of the macula as well as midperipheral 
RPE alterations in both eyes, which resembled intraretinal hemorrhages. Results: The ocular findings 
associated with peripheral exudative hemorrhagic chorioretinopathy may include midperipheral intraretinal 
hemorrhages, peripheral RPE mottling, subretinal fluid or hemorrhages, subretinal exudation, pigment 
epithelial detachments, and/or vitreous hemorrhages. Conclusions: Although this condition is rare, primary 
eye care providers should be aware of this unique clinical entity, its relationship to age-related macular 
degeneration, and when these patients require a referral to a retinal specialist. 
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Purpose: The purpose of this case report is to discuss an uncommon, unique hemorrhagic chorioretinopathy. Method: A 79-year-
old-white female presented to clinic with complaints of difficulty reading at close distances and seeing faces at far distances in both 
eyes. An 85-year old white female presented with no visual complaints but stated redness in the nasal corner of her right eye. This 
is a case report of two patients that presented with geographic atrophy of the macula as well as midperipheral RPE alterations in 
both eyes, which resembled intraretinal hemorrhages. Results: The ocular findings associated with peripheral exudative 
hemorrhagic chorioretinopathy may include midperipheral intraretinal hemorrhages, peripheral RPE mottling, subretinal fluid or 
hemorrhages, subretinal exudation, pigment epithelial detachments, and/or vitreous hemorrhages. Conclusions: Although this 
condition is rare, primary eye care providers should be aware of this unique clinical entity, its relationship to age-related macular 
degeneration, and when these patients require a referral to a retinal specialist.  
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INTRODUCTION  
Peripheral exudative hemorrhagic chorioretinopathy (PEHCR) is an uncommon bilateral peripheral retinal degeneration that affects 
elderly patients. The clinical findings of PEHCR vary from peripheral retinal pigment epithelial mottling, subretinal fluid or 
hemorrhages, subretinal exudation, pigment epithelial detachments to vitreous hemorrhages. Several conditions have been 
mistaken for PEHCR, such as retinal capillary hemangioma, retinal macroaneurysm, retinal telangiectasia, choroidal detachment 
and choroidal melanoma, with choroidal melanoma being the most common misdiagnosis for PEHCR. In 2005, Shields et al. found 
that out of 12,000 patients referred with presumed uveal melanoma, 13% were found to have PEHCR.1
 
We report two cases of 
PEHCR with its unique presentation in patients that were examined in our clinic on two separate occasions.  
 
CASE REPORT #1  
A 79-year-old-white female presented with complaints of difficulty reading at close distances and seeing faces at far distances in 
both eyes. She presented with best-corrected visual acuities of 20/80 OD and OS. Pupils were equal, round, and reactive to light, 
with no afferent pupillary defect (APD). Confrontation visual fields were full to finger counting OD, OS, and the motility was full 
range of motion OU. Slit lamp examination was remarkable for intraocular implants (PCIOL) OU. Dilated fundus examination (DFE) 
of the right eye revealed macular geographic atrophy and a blot hemorrhage 1.5 DD superior to the optic nerve. DFE of the left 
eye revealed macular geographic atrophy, and few dot-blot hemorrhages inferior to the optic nerve. Mid-peripheral retinal 
evaluation of both eyes revealed various areas of RPE changes, which resembled intra-retinal hemorrhages. Peripheral retinal 
evaluation of the right eye revealed a subretinal hemorrhage and a retinal scar due to a resolved subretinal hemorrhage. Peripheral 
retina evaluation of the left eye revealed a scar due to a resolved subretinal hemorrhage. The patient was referred to a retinal 
specialist for further evaluation, who confirmed the suspicion of peripheral exudative hemorrhagic chorioretinopathy (PEHCR) and 
non-exudative age-related macular degeneration OU and recommended observation without treatment.  
 
 
Figure 1. A digital photograph depicting multiple areas of mid-peripheral RPE alterations (blue arrows) suggestive of intraretinal 
hemorrhages and an isolated peripheral subretinal hemorrhage superiorly (green arrow). 
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Figure 2. Wide-field fundus photograph depicting geographic atrophy (blue arrow) as well as mid-peripheral and peripheral RPE 
alterations (green arrow) suggestive of intraretinal hemorrhages temporally. 
 
CASE REPORT #2  
An 85-year old white female presented with complaints of redness in the nasal corner of her right eye. Her best-corrected visual 
acuities were 20/70 OD and OS (she had no new visual complaints). Pupils were round and reactive to light OD, and fixed OS,  
 
with no APD by reverse testing. Confrontation visual fields were full to finger counting OD and OS, and she demonstrated a full 
range of ocular motion OU. Slit lamp examination was remarkable for corneal edema OS, and PCIOL OU. DFE of the right eye 
and left eye revealed soft drusen and geographic atrophy OU. Mid-peripheral retinal evaluation of both eyes revealed 
midperipheral RPE changes, which resembled intraretinal hemorrhages. Peripheral retinal evaluation of both eyes revealed RPE 
pigmentary changes. The patient was referred to a retinal specialist for further evaluation, who confirmed the diagnosis of 
peripheral exudative hemorrhagic chorioretinopathy (PEHCR) and non-exudative age-related macular degeneration OU. 
Management consisted of observation alone.  
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 Figure 3. A digital photograph of a patient with corneal edema depicting macular drusen (blue arrow) as well as mid-peripheral 
RPE alterations (green arrows) suggestive of intraretinal hemorrhages superiorly, nasally, and temporally. 
 
DISCUSSION  
PEHCR is a rare degenerative disease of the peripheral retina predominantly seen in elderly women and accompanied by 
hemorrhage and/or exudation.1,2Advanced age serves as a risk factor for development of PEHCR. Fluctuation of systemic blood 
pressure and anticoagulant use are additional risk factors for hemorrhages and play a role in recurrent hemorrhages.3
 
The clinical 
features of PEHCR are described based on peripheral and macular pathology. In 2016, Cebeci et al reviewed retrospectively the 
records of 12 elderly patients (21 eyes, 4 males and 8 females) diagnosed with PEHCR. They reported that 66.7% of the patients 
were referred with a diagnosis of a choroidal mass. Seventy-five percent (75%) had bilateral involvement. Subretinal hemorrhages 
and hemorrhagic/serous retinal pigment epithelial detachments were found in 71.4% of eyes, lipid exudation in 52.4%, chronic 
RPE alterations in 23.8%, subretinal fibrosis is 9.5% and vitreous hemorrhage in 4.8%. Drusen accompanied the PEHC lesions in 
52.4% of eyes, geographic atrophy was noted in 9.5%, and CNV scars in 9.5%.5
 
 
Due to their appearance as dark, elevated masses, PEHCR is often mistaken for choroidal melanoma. In 2009, Shields et al 
reviewed retrospectively the records of 146 elderly patients (173 eyes, 67% female, 99% Caucasian). All were referred for possible 
choroidal melanoma. The lesions were located temporally in 77% of eye, involved 1 or 2 quadrants in 92%, and were located 
between the equator and ora serrata in 89%. Subretinal hemorrhage was found in 78% of eyes, retinal exudation in 21%, RPE 
detachment in 28%, sub-RPE hemorrhage in 26%. Peripheral RPE alterations or drusen were found in 69% of ipsilateral and 42% 
of contralateral eyes. Macular RPE alterations, drusen, or CVM were found in 48% of ipsilateral and 56% of contralateral eyes. 
Lesion stability or regression was reported in 89% of eyes and progression in 11%. In addition, Shields et al. highlighted clinical 
features that can be used to distinguish between PEHCR and choroidal masses. These include a more peripheral location of the 
lesions in PEHCR, absence of sentinel vessels on anterior segment, retinal exudation, macular and peripheral RPE alterations, 
appearance of hypofluorescence on fluorescein angiography (FA) and absence of intrinsic vascular pulsation and presence of a 
clot retraction cleft on ultrasonography.2 
 
Patients can be asymptomatic, otherwise they may complain of visual loss, floaters, photopsia, metamorphopsia, and 
scotoma.3PEHCR lesions are commonly located in the temporal retina between the equator and the ora serrata.2-5
 
Visual acuity in 
PEHCR can be affected due to presence of vitreous hemorrhages, macular edema and/or accompanying AMD- related findings 
such as drusen, choroidal neovascular membrane (CNV) and geographic atrophy. Shields et al. observed age-related macular 
changes in 17% of ipsi- and 27% of contralateral eyes in PEHCR patients.2
 
PEHCR is diagnosed by patient history, 
ophthalmoscopic findings and testing. Fundus fluorescein angiography findings include hypofluorescence consistent with 
hemorrhage in the lesion area and irregular hyperfluorescence shown by CNV and homogenous hyperfluorescence typical of 
serous PED in the periphery. Indocyanine green angiography can show polypoid formations and abnormal choroidal 
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vasculature.4Usually, PECHR remains stable or regresses spontaneously, which can result in atrophy, fibrosis, or hyperplasia.5The 
treatment options for PEHCR include the following: monitoring, vitrectomy, intravitreal anti-VEGF therapy, cryotherapy, laser 
photocoagulation, or photodynamic therapy (PDT).6,7 
 
The prognosis of PEHCR depends on the location of the lesion. In cases where the central vision or macula remain unaffected, 
observation without intervention is recommended as the disease may spontaneously regress.8Laser photocoagulation or PDT are 
reserved for cases that are threatening the macula and for peripheral polyps.9
 
A pars plana vitrectomy is recommended in rare 
cases where vitreous hemorrhage or massive subretinal hemorrhage are present.10
 
Choroidal neovascular membranes in the 




PEHCR is an uncommon, peripheral retinal degeneration that primarily affects elderly patients. Ocular findings may include 
midperipheral RPE alterations, which resemble intraretinal hemorrhages, peripheral RPE mottling, subretinal fluid or hemorrhages, 
subretinal exudation, pigment epithelial detachments, and/or vitreous hemorrhages. Although this condition is rare, primary eye 
care providers should be aware of this unique clinical entity, its relationship to age-related macular degeneration, and that if there 
is macular involvement or a rapidly progressive lesion, a referral to a retinal specialist is warranted.  
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